Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Arcinova Invests in State of the Art LC-MS Equipment

Designed for the most demanding bioanalytical quantitative UPLC-MS/MS applications, the latest Waters Xevo TQ XS has provided ARCINOVA with the ultimate in tandem quadrupole performance to ensure class leading sensitivity and robustness. In combination with our MSIA (mass spectrometric immuno-assay) extraction system the Xevo provides us with a powerful and sensitive hybrid LC-MS  solution for peptide and biomolecule analysis. For any application, either small or large molecules, our new Xevo mass spectrometer and I-Class Acquity UPLC system ensures that ARCINOVA can provide our clients with the highest quality scientific information when they need it most.

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.